$0.859
-0.021 (-2.39%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GDTC Prediction & Forecast by Similar Chart Analysis
Alphio's GDTC stock price prediction model matches the current CytoMed Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.86 (-0.18%). The 1-week path is $0.84 (-2.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy CytoMed Therapeutics Ltd Stock?
CytoMed Therapeutics Ltd (GDTC) is not a good buy right now due to its poor financial performance and negative momentum indicators. The current price is $0.86, with a 52-week high of $2.29, indicating a significant drop of 62.4%. Additionally, the RSI is at 31.414, suggesting that the stock is oversold, but this does not guarantee a rebound. The gross margin has improved to 87.51%, but the company continues to report negative net income, with a loss of -885,226 SGD in the latest quarter. The main risk is the declining stock price, which has dropped 56.4% over the past year, indicating ongoing challenges for the company.
GDTC stock price ended at $0.86 on Friday, after losing -2.39%
CytoMed Therapeutics Ltd (GDTC) last closed at $0.859, losing -2.39%. These facts feed the 1-day and 1-week GDTC price prediction above.
Forecast Drivers
CytoMed Therapeutics Ltd (GDTC) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GDTC, ranked by similarity.
Seasonality analysis for GDTC
Historically the probability of a positive November return for GDTC is 0.00%. January offers the highest probability of a positive month at 4.92%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.